Impact of High Dietary Fiber on Microbiome and Vaccine Responses
2 other identifiers
interventional
31
1 country
1
Brief Summary
To learn if diet can enhance the microbes (such as bacteria and viruses) found in your gut and improve the body's immune response to the influenza (flu) vaccine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 23, 2022
CompletedFirst Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
October 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 2, 2029
March 4, 2026
March 1, 2026
6.4 years
September 19, 2022
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of dietary intervention prior to seasonal influenza vaccination defined as ≥ 80% of subjects being compliant with the intervention in the cohort
through study completion an average of 1 year.
Study Arms (2)
High-Fiber Diet (HFD) Intervention
EXPERIMENTALParticipants are expected to eat only the study meals and snacks provided
Prebiotic Food-Enriched Diet (PreFED) Intervention
EXPERIMENTALParticipants are expected to incorporate study snacks and meal components provided into your usual diet.
Interventions
Participants are assigned to the high fiber diet, all meals and snacks will be provided to participants during the study. This diet includes fruits, vegetables and whole grains, a maximum of 18 oz. cooked red meat (including beef, pork, and lamb) per week, and little or no processed meats or added sugars.
Participants are assigned to the prebiotic food enriched diet, participants will receive 2 prepared snacks and 1 meal component (a key prebiotic ingredient to incorporate into meals and simple recipes) each day. Participants will also receive a handout that includes key prebiotic foods to incorporate into your own diet.
Eligibility Criteria
You may qualify if:
- MD Anderson employees with existing MRNs
- Body Mass Index (BMI) 18.5-40 kg/m2
- Age 18 or older
- Intends to receive the seasonal influenza vaccine at MD Anderson through Employee Health (starting Fall of 2022)
- Willing to adhere to the provided dietary interventions
- Willing to provide blood and stool specimens, complete diet questionnaires and logs, and pick up food on-site within the study schedule
- English-speaking
- Has easy access to a scale at home, work, or in their community
You may not qualify if:
- Contraindication to the recommended annual influenza vaccine
- Medical contraindications to the intervention diet
- Major dietary restrictions (including vegetarian or vegan diets) or food allergies
- Unable or unwilling to undergo study procedures
- Has diabetes mellitus requiring medical treatment
- Has inflammatory bowel disease
- Has a history of bariatric surgery
- Has a history of major gastrointestinal surgery (not including appendectomy or cholecystectomy)
- Antibiotic use within 30 days of study initiation or planned antibiotic treatment during study course
- Habitual consumption of a high fiber diet
- Use of a supplement containing fiber/prebiotics/probiotics within 30 days of study initiation
- Women who are pregnant, planning to become pregnant, or who are lactating may not be included in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Wargo, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2022
First Posted
October 4, 2022
Study Start
August 23, 2022
Primary Completion (Estimated)
January 2, 2029
Study Completion (Estimated)
January 2, 2029
Last Updated
March 4, 2026
Record last verified: 2026-03